Szilvia Veszelka
Szilvia Veszelka
Research Associate, Biological Research Centre, Szeged, Hungary
Verified email at brc.mta.hu - Homepage
Title
Cited by
Cited by
Year
Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood–brain barrier penetration models
É Hellinger, S Veszelka, AE Tóth, F Walter, Á Kittel, ML Bakk, K Tihanyi, ...
European journal of pharmaceutics and biopharmaceutics 82 (2), 340-351, 2012
1662012
The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells
IE András, MA Deli, S Veszelka, K Hayashi, B Hennig, M Toborek
Journal of Cerebral Blood Flow & Metabolism 27 (8), 1431-1443, 2007
1392007
Role of the blood–brain barrier in the nutrition of the central nervous system
P Campos-Bedolla, FR Walter, S Veszelka, MA Deli
Archives of medical research 45 (8), 610-638, 2014
1282014
Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer
Z Ujhelyi, F Fenyvesi, J Váradi, P Fehér, T Kiss, S Veszelka, M Deli, ...
European journal of pharmaceutical sciences 47 (3), 564-573, 2012
1242012
A versatile lab-on-a-chip tool for modeling biological barriers
FR Walter, S Valkai, A Kincses, A Petneházi, T Czeller, S Veszelka, ...
Sensors and Actuators B: Chemical 222, 1209-1219, 2016
1122016
Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages
S Veszelka, M Pásztói, AE Farkas, I Krizbai, NTK Dung, M Niwa, ...
Neurochemistry international 50 (1), 219-228, 2007
1052007
Kinetic analysis of the toxicity of pharmaceutical excipients Cremophor EL and RH40 on endothelial and epithelial cells
L Kiss, FR Walter, A Bocsik, S Veszelka, B Ózsvári, LG Puskás, ...
Journal of pharmaceutical sciences 102 (4), 1173-1181, 2013
1002013
Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells
FL Cardoso, A Kittel, S Veszelka, I Palmela, A Tóth, D Brites, MA Deli, ...
PloS one 7 (5), e35919, 2012
892012
Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue
S Horvát, A Fehér, H Wolburg, P Sipos, S Veszelka, A Tóth, L Kis, ...
European journal of pharmaceutics and biopharmaceutics 72 (1), 252-259, 2009
882009
Restraint stress-induced morphological changes at the blood-brain barrier in adult rats
P Sántha, S Veszelka, Z Hoyk, M Mészáros, FR Walter, AE Tóth, L Kiss, ...
Frontiers in molecular neuroscience 8, 88, 2016
702016
Patented in vitro blood-brain barrier models in CNS drug discovery
A Tóth, S Veszelka, S Nakagawa, M Niwa, M A Deli
Recent Patents on CNS Drug Discovery (Discontinued) 6 (2), 107-118, 2011
632011
Reversible opening of intercellular junctions of intestinal epithelial and brain endothelial cells with tight junction modulator peptides
A Bocsik, FR Walter, A Gyebrovszki, L Fülöp, I Blasig, S Dabrowski, ...
Journal of Pharmaceutical Sciences 105 (2), 754-765, 2016
602016
Docosahexaenoic acid reduces amyloid-β induced toxicity in cells of the neurovascular unit
S Veszelka, AE Tóth, FR Walter, Z Datki, E Mózes, L Fülöp, Z Bozsó, ...
Journal of Alzheimer's Disease 36 (3), 487-501, 2013
562013
The effect of sucrose esters on a culture model of the nasal barrier
L Kürti, S Veszelka, A Bocsik, NTK Dung, B Ózsvári, LG Puskás, Á Kittel, ...
Toxicology in Vitro 26 (3), 445-454, 2012
552012
Effect of nicotine and polyaromtic hydrocarbons on cerebral endothelial cells
P Hutamekalin, AE Farkas, A Orbók, I Wilhelm, P Nagyőszi, S Veszelka, ...
Cell biology international 32 (2), 198-209, 2008
512008
Comparison of a rat primary cell-based blood-brain barrier model with epithelial and brain endothelial cell lines: gene expression and drug transport
S Veszelka, A Tóth, FR Walter, AE Tóth, I Gróf, M Mészáros, A Bocsik, ...
Frontiers in molecular neuroscience 11, 166, 2018
482018
In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration
L Kürti, R Gáspár, Á Márki, E Kápolna, A Bocsik, S Veszelka, C Bartos, ...
European Journal of Pharmaceutical Sciences 50 (1), 86-92, 2013
432013
Human serum amyloid P component attenuates the bacterial lipopolysaccharide-induced increase in blood–brain barrier permeability in mice
S Veszelka, Z Urbányi, T Pázmány, L Németh, I Obál, NTK Dung, ...
Neuroscience letters 352 (1), 57-60, 2003
412003
Randomly methylated β‐cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco‐2 cell monolayer
F Fenyvesi, T Kiss, É Fenyvesi, L Szente, S Veszelka, MA Deli, J Váradi, ...
Journal of pharmaceutical sciences 100 (11), 4734-4744, 2011
402011
Acute effects of short‐chain alkylglycerols on blood‐brain barrier properties of cultured brain endothelial cells
P Hülper, S Veszelka, FR Walter, H Wolburg, P Fallier‐Becker, J Piontek, ...
British journal of pharmacology 169 (7), 1561-1573, 2013
362013
The system can't perform the operation now. Try again later.
Articles 1–20